pyridinoline has been researched along with Pulmonary Disease, Chronic Obstructive in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boguszewski, CL; Borba, V; Dempster, D; Gamsjaeger, S; Jorgetti, V; Klaushofer, K; Moreira, CA; Paschalis, EP | 1 |
| Lin, YY; Ma, S; Turino, GM | 1 |
2 other study(ies) available for pyridinoline and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Fragility Fracture Incidence in Chronic Obstructive Pulmonary Disease (COPD) Patients Associates With Nanoporosity, Mineral/Matrix Ratio, and Pyridinoline Content at Actively Bone-Forming Trabecular Surfaces.
Topics: Amino Acids; Bone Matrix; Cancellous Bone; Female; Fractures, Bone; Humans; Incidence; Middle Aged; Minerals; Nanoparticles; Osteogenesis; Porosity; Pulmonary Disease, Chronic Obstructive; Regression Analysis | 2017 |
Quantitation of desmosine and isodesmosine in urine, plasma, and sputum by LC-MS/MS as biomarkers for elastin degradation.
Topics: Amino Acids; Biomarkers; Case-Control Studies; Chromatography, Liquid; Desmosine; Elastin; Humans; Hydrochloric Acid; Hydrolysis; Isodesmosine; Pulmonary Disease, Chronic Obstructive; Reproducibility of Results; Sensitivity and Specificity; Sputum; Tandem Mass Spectrometry | 2011 |